BG106373A - Heterocyclic compounds inhibiting angiogenesis - Google Patents

Heterocyclic compounds inhibiting angiogenesis

Info

Publication number: BG106373A
Authority: BG; Bulgaria
Prior art keywords: group; inhibiting angiogenesis; alkyl; heterocyclic compounds; stands
Prior art date: 1999-08-02

Application number

BG06373A

Other languages

Bulgarian (bg)

English (en)

Inventor

Nandor Makk

Gabor Ambrus

Aniko Tegdes

Andras Jeney

Ferenc Timar

Original Assignee

Ivax Drug Research Institute Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-02

Filing date

2002-01-31

Publication date

2002-09-30

2002-01-31 Application filed by Ivax Drug Research Institute Ltd filed Critical Ivax Drug Research Institute Ltd

2002-09-30 Publication of BG106373A publication Critical patent/BG106373A/xx

Links

230000033115 angiogenesis Effects 0.000 title abstract 2
230000002401 inhibitory effect Effects 0.000 title abstract 2
150000002391 heterocyclic compounds Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
206010027476 Metastases Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
206010029113 Neovascularisation Diseases 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
-1 acids salts Chemical class 0.000 abstract 1
239000002671 adjuvant Substances 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
125000000547 substituted alkyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrane Compounds (AREA)

BG06373A 1999-08-02 2002-01-31 Heterocyclic compounds inhibiting angiogenesis BG106373A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU9902628A HUP9902628A3 (en)	1999-08-02	1999-08-02	Angiogenesis inhibiting borrelidin derivatives, their use and pharmaceutical compositions containing them
PCT/HU2000/000088 WO2001009113A2 (en)	1999-08-02	2000-08-02	Heterocyclic compounds inhibiting angiogenesis

Publications (1)

Publication Number	Publication Date
BG106373A true BG106373A (en)	2002-09-30

Family

ID=89998954

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG06373A BG106373A (en)	1999-08-02	2002-01-31	Heterocyclic compounds inhibiting angiogenesis

Country Status (32)

Country	Link
US (1)	US6815465B1 (de)
EP (1)	EP1206462B1 (de)
JP (1)	JP2003506366A (de)
KR (1)	KR20020068495A (de)
CN (1)	CN1243746C (de)
AP (1)	AP1383A (de)
AT (1)	ATE241611T1 (de)
AU (1)	AU772206B2 (de)
BG (1)	BG106373A (de)
BR (1)	BR0012968A (de)
CA (1)	CA2378176A1 (de)
CZ (1)	CZ2002405A3 (de)
DE (1)	DE60003045T2 (de)
DK (1)	DK1206462T3 (de)
ES (1)	ES2200900T3 (de)
HK (1)	HK1048995B (de)
HR (1)	HRP20020103B1 (de)
HU (1)	HUP9902628A3 (de)
IL (1)	IL147904A (de)
IS (1)	IS2137B (de)
MX (1)	MXPA02001117A (de)
NO (1)	NO20020485L (de)
NZ (1)	NZ517422A (de)
OA (1)	OA12004A (de)
PL (1)	PL354281A1 (de)
PT (1)	PT1206462E (de)
RU (1)	RU2247723C2 (de)
SK (1)	SK1822002A3 (de)
UA (1)	UA74341C2 (de)
WO (1)	WO2001009113A2 (de)
YU (1)	YU7302A (de)
ZA (1)	ZA200200838B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6376514B1 (en)	2000-10-17	2002-04-23	The Procter & Gamble Co.	Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) *	2000-10-17	2004-02-17	The Procter & Gamble Company	Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
AU2003218110A1 (en)	2002-03-12	2003-09-29	Bristol-Myers Squibb Company	C3-cyano epothilone derivatives
GB0230217D0 (en) *	2002-12-27	2003-02-05	Biotica Tech Ltd	Borrelidin-producing polyketide synthase and its uses
US8440217B1 (en)	2005-06-15	2013-05-14	Mawaheb M. EL-Naggar	Method and system with contact lens product for treating and preventing adverse eye conditions
GB0609981D0 (en) *	2006-05-19	2006-06-28	Biotica Tech Ltd	Novel compounds
GB0713563D0 (en) *	2007-07-13	2007-08-22	Biotica Tech Ltd	Methods of screening for anti-angiogenic compounds
ES2423932T3 (es) *	2007-08-27	2013-09-25	Basf Se	Compuestos de pirazol para controlar plagas de invertebrados
DE102008014077A1 (de)	2008-03-13	2009-09-17	Discovery Partner International Gmbh	Borrelidin-Derivate
WO2009141786A2 (en) *	2008-05-21	2009-11-26	Piramal Life Sciences Limited	Anti-inflammatory compounds
DK3034522T3 (en)	2014-12-15	2019-04-15	Borealis Ag	Use of a polypropylene composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2099334C1 (ru) *	1986-06-06	1997-12-20	Американ Цианамид Компани	Макролидные соединения, композиция, обладающая антибиотической активностью, ветеринарная композиция, инсектоакарицидонематоцидная композиция и способ уничтожения насекомых и/или клещей, нематод
JPH08173176A (ja)	1994-12-22	1996-07-09	Mercian Corp	血管新生阻害剤
JP3786461B2 (ja)	1996-02-22	2006-06-14	メルシャン株式会社	新生理活性物質

1999
- 1999-08-02 HU HU9902628A patent/HUP9902628A3/hu unknown
2000
- 2000-08-02 HK HK03101165.4A patent/HK1048995B/zh not_active IP Right Cessation
- 2000-08-02 CN CNB008123578A patent/CN1243746C/zh not_active Expired - Fee Related
- 2000-08-02 JP JP2001514316A patent/JP2003506366A/ja not_active Withdrawn
- 2000-08-02 KR KR1020027001484A patent/KR20020068495A/ko not_active Ceased
- 2000-08-02 AT AT00949831T patent/ATE241611T1/de not_active IP Right Cessation
- 2000-08-02 BR BR0012968-2A patent/BR0012968A/pt not_active IP Right Cessation
- 2000-08-02 IL IL14790400A patent/IL147904A/xx not_active IP Right Cessation
- 2000-08-02 AU AU63090/00A patent/AU772206B2/en not_active Ceased
- 2000-08-02 HR HR20020103A patent/HRP20020103B1/xx not_active IP Right Cessation
- 2000-08-02 PL PL00354281A patent/PL354281A1/xx not_active Application Discontinuation
- 2000-08-02 DE DE60003045T patent/DE60003045T2/de not_active Expired - Fee Related
- 2000-08-02 UA UA2002010814A patent/UA74341C2/uk unknown
- 2000-08-02 YU YU7302A patent/YU7302A/sh unknown
- 2000-08-02 CZ CZ2002405A patent/CZ2002405A3/cs unknown
- 2000-08-02 CA CA002378176A patent/CA2378176A1/en not_active Abandoned
- 2000-08-02 NZ NZ517422A patent/NZ517422A/en unknown
- 2000-08-02 RU RU2002105518/04A patent/RU2247723C2/ru not_active IP Right Cessation
- 2000-08-02 SK SK182-2002A patent/SK1822002A3/sk unknown
- 2000-08-02 DK DK00949831T patent/DK1206462T3/da active
- 2000-08-02 OA OA1200200042A patent/OA12004A/en unknown
- 2000-08-02 WO PCT/HU2000/000088 patent/WO2001009113A2/en not_active Ceased
- 2000-08-02 PT PT00949831T patent/PT1206462E/pt unknown
- 2000-08-02 MX MXPA02001117A patent/MXPA02001117A/es active IP Right Grant
- 2000-08-02 AP APAP/P/2002/002413A patent/AP1383A/en active
- 2000-08-02 US US10/048,659 patent/US6815465B1/en not_active Expired - Fee Related
- 2000-08-02 EP EP00949831A patent/EP1206462B1/de not_active Expired - Lifetime
- 2000-08-02 ES ES00949831T patent/ES2200900T3/es not_active Expired - Lifetime
2002
- 2002-01-30 ZA ZA200200838A patent/ZA200200838B/en unknown
- 2002-01-30 NO NO20020485A patent/NO20020485L/no not_active Application Discontinuation
- 2002-01-31 BG BG06373A patent/BG106373A/xx unknown
- 2002-02-01 IS IS6258A patent/IS2137B/xx unknown

Also Published As

Publication number	Publication date
EP1206462A2 (de)	2002-05-22
AP1383A (en)	2005-04-05
EP1206462B1 (de)	2003-05-28
HRP20020103A2 (en)	2004-02-29
CN1243746C (zh)	2006-03-01
IL147904A0 (en)	2002-08-14
UA74341C2 (uk)	2005-12-15
AP2002002413A0 (en)	2002-03-31
IS2137B (is)	2006-08-14
DK1206462T3 (da)	2003-09-29
YU7302A (sh)	2004-09-03
CZ2002405A3 (cs)	2002-07-17
HU9902628D0 (en)	1999-10-28
JP2003506366A (ja)	2003-02-18
HK1048995A1 (en)	2003-04-25
PT1206462E (pt)	2003-10-31
HK1048995B (zh)	2006-07-21
IL147904A (en)	2005-09-25
ZA200200838B (en)	2003-08-27
IS6258A (is)	2002-02-01
CN1372556A (zh)	2002-10-02
NO20020485L (no)	2002-03-21
ATE241611T1 (de)	2003-06-15
AU772206B2 (en)	2004-04-22
AU6309000A (en)	2001-02-19
HRP20020103B1 (en)	2005-06-30
BR0012968A (pt)	2002-05-14
RU2247723C2 (ru)	2005-03-10
DE60003045D1 (de)	2003-07-03
HUP9902628A3 (en)	2001-07-30
MXPA02001117A (es)	2003-08-20
PL354281A1 (en)	2003-12-29
CA2378176A1 (en)	2001-02-08
KR20020068495A (ko)	2002-08-27
WO2001009113A2 (en)	2001-02-08
HUP9902628A2 (hu)	2001-05-28
DE60003045T2 (de)	2004-04-01
NO20020485D0 (no)	2002-01-30
WO2001009113A3 (en)	2001-06-14
US6815465B1 (en)	2004-11-09
SK1822002A3 (en)	2002-08-06
NZ517422A (en)	2005-02-25
OA12004A (en)	2006-04-18
ES2200900T3 (es)	2004-03-16

Publication	Publication Date	Title
HUP0400851A2 (hu)	2004-07-28	Dihidro-benzo[b][1,4]diazepin-2-on-származékok, mint MGluR2 II antagonisták, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ATE253545T1 (de)	2003-11-15	Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
NO20055714L (no)	2006-02-02	Inhibitorer av fosfatidylinositol 3-kinase
DE69232022D1 (de)	2001-10-04	Naphthyridinderivate als Angiotensin-II-Antagonist-Inhibitoren
KR940021063A (ko)	1994-10-17	퀴놀론카르복실산 유도체, 이의 제조방법 및 용도
BG66087B1 (bg)	2011-03-31	Хинолинонови производни като тирозин киназни инхибитори
CA2258165A1 (en)	1997-12-31	N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
TW369533B (en)	1999-09-11	Quinoline compounds, process for preparing them and pharmaceutical composition containing them
EP1256574A4 (de)	2004-09-01	Stickstoff-enthaltende verbindungen mit kinasehemmender wirkung sowie diese enthaltende medikamente
NO20070557L (no)	2007-01-30	Ftalazinderivater som PARP-inhibitorer
TW200407308A (en)	2004-05-16	Heterocyclic compound having inhibitory activity against HIV integrase
BG103984A (en)	2000-09-29	Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
TW200738682A (en)	2007-10-16	Isoquinoline derivatives
AP1541A (en)	2006-01-11	New thiadazoles and oxadiazoles and their use as phosphodiesterase - 7 inhibitors.
TR200101155T2 (tr)	2001-09-21	4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
DE60139639D1 (de)	2009-10-01	Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung
BG100154A (en)	1996-07-31	Carbazole derivatibes having inhibiting effect to 17,20-lyase
CA2238817A1 (en)	1997-07-10	1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
IL151201A0 (en)	2003-04-10	Alkylated imidazopyridine derivatives and pharmaceutical compositions containing the same
WO2001009113A3 (en)	2001-06-14	Heterocyclic compounds inhibiting angiogenesis
TR200101711T2 (tr)	2001-12-21	Antihistaminik spiro bileşikler.
TW429256B (en)	2001-04-11	1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
DE69230141D1 (de)	1999-11-18	Von pyridin und imidazol abgeleitete mittel für kardiovaskuläre krankheiten
FR2672213B1 (fr)	1995-03-10	Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.
IL151198A0 (en)	2003-04-10	Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same